Shuman Zhang
Zhong Lun Law FirmZhong Lun Law Firm‘s dedicated healthcare and life sciences practice is recommended for its breadth of capability in this space, covering M&A deals, investment funds, compliance advice and litigation, including trade secrets infringement cases. Changyu Fu is recommended for disputes and arbitration work in this field, including antitrust and criminal matters. Jim Qiu, who specialises in compliance advice for multinational clients operating in China, is also key, as is healthcare and medical technology IP expert Helen Cheng. Dongmei Wang and Yongbin Ge are further names to note. Among the more junior partners, medical product liability disputes expert Yuru Zuo and Qi Lan, who brings the experience of formerly having worked at the State Intellectual Property Office, are the standout names, while associate Shuman Zhang is also highly recommended. Clients describe the team as 'customer-focused, responsive, and problem-solving'.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The team of lawyers performed well in providing services for our Healthcare investment project. Their professionalism and legal knowledge are profound, and they are comfortable in applying regulations. They are customer-focused, responsive, and problem-solving. Excellent teamwork and smooth communication.’
‘Deep expertise and a great service attitude. Always responds quickly to our needs and provides effective solutions.'
Key clients
- Pfizer Investment Co.,Ltd
- GlaxoSmithKline (China) R&D Co., Ltd.
- Beaufour-IPSEN (Tianjin) Pharmaceutical Co., Ltd.
- Shanghai Roche Pharmaceuticals Ltd.
- Nestle (China) Ltd.
- Fosun Kite Biotechnology Co., Ltd.
- PepsiCo Asia R&D Center Ltd.
- China National Medicines Corporation Ltd.
- Astellas Pharmaceutical(China)Co.,Ltd.
- Beijing Novogene Technology Co.
- Beijing Xiaomi Mobile Software Co.
- Terumo (China) Investment Co.
- Asymchem Laboratories(Tianjin)Co.,Ltd.
- Nanjing GenScript Biotechnology Co., Ltd.
- China National Medicines Corporation Ltd.
- Beijing Stemexcel Technical Co.,Ltd.
- Shenzhen Smoore Technology Limited
- Porton Biologics Ltd.
- MSD China Holding Co., Ltd.
- United Imaging Healthcare
- Zenas BioPharma
- Sequoia Capital China
- Doma Biopharmaceutical (Suzhou) Co., Ltd.
- Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- China Mobile Equity Fund
- China Mobile Investment Holding Co., Ltd.
- Unisplendour Corporation
- Guoxin Micro
- Whirlpool (China) Co., Ltd
- Ansteel Group
- T.Y. Lin International Ltd.
- Eagle Quest International Ltd.
- Capcon Limited
- Sichuan Qian Li Beoka Medical Technology Co.,ltd.
- Qingdao Magene Intelligent Technology Co., Ltd.
- AltoBeam Inc.
- Shanghai Enflame Technology Co., Ltd.
- Shenzhen Jaguar Microsystems Co., Ltd.
- TREX Technologies
- Shanghai Yibu Semiconductor Ltd.
- Arcomicro Ltd.
- Redhill Capital
- Jadestone Capital
Work highlights
- Regularly advising Pfizer Investment on various compliance matters in area of life sciences and healthcare as well as assisting it in enhancing and updating its compliance system.
- Advised Sequoia Capital China, one of the top venture capital firms, on their CNY 265 million Series A equity investment in BoomRay Pharmaceuticals as the lead investor with other co-investors.
- Acted as the lead counsel of Chengdu Yunke Pharmaceutical Co., Ltd in defending a dispute lawsuit of technical secret infringement raised by a clinician.
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Helen Cheng
Zhong Lun Law FirmNext Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
The lawyer(s) leading their teams.
Helen Cheng, Changyu Fu, Dongmei Wang, Yongbin Ge, Jim Qiu